We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App


31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Rehabilitation Device Helps Reduce Thromboembolism Risk

By HospiMedica International staff writers
Posted on 10 Jun 2014
Print article
Image: The VPULSE DVT and PE prevention system (Photo courtesy of Cothera).
Image: The VPULSE DVT and PE prevention system (Photo courtesy of Cothera).
A novel deep vein thrombosis (DVT) prevention device helps hospitals control readmission related costs, while supporting clinician treatment plans.

The VPULSE System is single user, postsurgical rehabilitation device designed to prevent venous thromboembolism (VTE) and subsequent pulmonary embolism (PE) in the hospital, clinic, and home environments. The system consists of a control unit, tubing set, and a choice of various joint-specific application wraps that deliver the therapeutic treatments. These include intermittent pneumatic compression (IPC) therapy to prevent hospital-acquired VTE; intermittent dynamic compression therapy to reduce swelling; and controlled cold therapy to reduce pain and swelling.

Each of the separate treatment modalities is considered essential for effective postoperative rehabilitation and the prevention of complications. The patient can apply one or two sequential compression therapy pads to the calves for preventative treatment of VTE; and/or one thermal-compression pad to a specific body part such as the knee or shoulder for cold therapy; and/or dynamic compression therapy to manage pain and swelling for post-operative recovery. The VPULSE System is a product of Cothera (Plano, TX, USA), and has received the European Community CE marking of approval.

“The VPULSE System combines DVT prevention and post-orthopedic procedure rehabilitation and places these effective therapies and significant convenience in the hands of the patients,” said Howard Edelman, general manager of Cothera. “The fact that the VPULSE can be used continuously from the hospital to home setting, while providing physicians with compliance data via a data card, will dramatically reduce instances of DVT complications.”

DVT refers to the development of blood clots, or thrombi, within a deep vein. Typically it occurs in the thigh or calf and can develop after any major surgery. Symptoms may include pain, swelling, skin discoloration, or no signs at all. DVT risk is greatest between two and five days after surgery, with a second peak risk period at about 10 days after surgery (after the patient has been discharged). A consecutive PE can occur when a clot breaks free and lodges in the lungs. PE has been reported to occur in over one third of DVT patients and frequently causes sudden death.

Related Links:


Gold Member
12-Channel ECG
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
Mobile Digital Baby Scale
seca 334

Print article


Surgical Techniques

view channel
Image: The ExcelsiusFlex and ACTIFY 3D Total Knee System have been granted FDA 510(k) clearance (Photo courtesy of Globus Medical)

New Robotic Navigation Platform Provides Surgeons Best-In-Class Solution for Orthopedic Treatment

Globus Medical (Audubon, PA, USA) has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new robotic navigation platform, ExcelsiusFlex, tailored for total knee arthroplasty... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more


view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.